- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0245254

About Livealth Biopharma Private Limited
Data last updated:
Livealth Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24296MH2016PTC274406. Its GSTIN is 27AADCL0404F1Z2 (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Dattatray Patil and Bhavesh Prabhudas Kanabar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹58.19 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹6.66 Cr (net margin 11.4%) and EBITDA of ₹9.13 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 30% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹78.01 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Livealth Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0245254). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website livealthbiopharma.com.
Company details
Recognitions & Rankings of Livealth Biopharma
Contact details
Livealth Biopharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is livealthbiopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address606 Dev Plaza Opp. Andheri Fire Brigade, S. V. Road, Mumbai, Maharashtra, India – 400058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Livealth Biopharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Livealth Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Livealth Biopharma Private Limited, buy the company report.
Financials of Livealth Biopharma Private Limited
FY 2025 filings availableLivealth Biopharma Private Limited reported revenue of ₹58.19 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 30%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | ||||
| Net Profit Margin | 11.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Livealth Biopharma Private Limited, buy the company report.
Board of directors of Livealth Biopharma Private Limited
Livealth Biopharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Dattatray Patil | Director | 15 Mar 2016 | 10 Years 8 Months | Current |
| Bhavesh Prabhudas Kanabar | Director | 15 Mar 2016 | 10 Years 8 Months | Current |
Peer comparison
Livealth Biopharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ocean Healthcare Private Limited | ₹58.49 Cr (FY 2025) | -8.0% | Egmore Nungambakkm, Tamil Nadu, India | |||
| Unimarck Pharma (India) Limited | ₹58.24 Cr (FY 2025) | 7.0% | Chandigarh, India | |||
| Livealth Biopharma Private Limitedthis company | ₹58.19 Cr (FY 2025) | ₹6.66 Cr | 11.4% | -9.0% | 29 | Mumbai, Maharashtra, India |
| Uma Ayurvedics Private Limited | ₹58.01 Cr (FY 2024) | 61.0% | Uttar Pradesh, India | |||
| Stedman Pharmaceuticals Private Limited | ₹57.77 Cr (FY 2024) | 9.0% | Chennai, Tamil Nadu, India | |||
| And Healthcare Limited | ₹57.48 Cr (FY 2024) | 24.0% | Mohali, Punjab, India | |||
| Alna Biotech Private Limited | ₹57.47 Cr (FY 2024) | 3.0% | Chandigarh, India |
To see the full peer comparison of Livealth Biopharma Private Limited, buy the company report.
Auditor
Livealth Biopharma Private Limited is audited by ShethMehta&CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ShethMehta&CO | FY 2023 | 121835W |
Shareholding
The shareholding of Livealth Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Livealth Biopharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jan 2019 | 100234397 | Others | ₹78.01 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Livealth Biopharma Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Hab Pharmaceutical and Research Limited | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Hab Pharmaceutical and Research Limited | Pending |
To see the full case history of Livealth Biopharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Livealth Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Livealth Biopharma Private Limited has a workforce of 29 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 29 |
| FY 2025-26 |
To see the full employee and EPFO history of Livealth Biopharma Private Limited, buy the company report.
GST
Livealth Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCL0404F1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Livealth Biopharma Private Limited, buy the company report.
Recent activity
Livealth Biopharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Bhavesh Prabhudas Kanabar was appointed as Director on 15 Mar 2016.
Frequently asked questions
Livealth Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 March 2016 (10+ years old) and is registered under CIN U24296MH2016PTC274406.
Livealth Biopharma has 2 current directors:
- Sanjay Dattatray Patil - Director
- Bhavesh Prabhudas Kanabar - Director
The latest financial statements of Livealth Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Livealth Biopharma is 27AADCL0404F1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Livealth Biopharma is U24296MH2016PTC274406. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Livealth Biopharma has 2 court cases on record: 2 filed against it. 2 are pending.
Livealth Biopharma was incorporated on 15 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Livealth Biopharma by revenue are Ocean Healthcare Private Limited, Unimarck Pharma (India) Limited, Uma Ayurvedics Private Limited, Stedman Pharmaceuticals Private Limited, And Healthcare Limited and 1 more, all in the Pharma industry (Biopharma, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhavesh Prabhudas Kanabar was appointed as Director on 15 Mar 2016. Sanjay Dattatray Patil was appointed as Director on 15 Mar 2016.
Yes, Livealth Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0245254).
Livealth Biopharma can be reached through the website livealthbiopharma.com. Its registered office is in Mumbai, Maharashtra, India.

